Zeeshan Mansuri, MD

Department of Psychiatry, Yale New Haven School of Medicine, New Haven, Connecticut

  • 34Articles
  • 356.5KReads
  • 2019–2026Active
  • 90Collaborators
  • 86Citations

About

Zeeshan Mansuri, MD is affiliated with Department of Psychiatry, Yale New Haven School of Medicine, New Haven, Connecticut. Zeeshan Mansuri has authored or co-authored 34 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2019 and 2026. Their work focuses on COVID, Child and Adolescent Psychiatry, Addiction, Psychiatry, and Schizophrenia/Schizoaffective Disorders.

Publications

PCC
Umbilical Cord Blood Infusion and Autism Management
Systematic Review

Umbilical Cord Blood Infusion and Autism Management

June 2, 2022

In this review, the authors provide an overview of the role of umbilical cord blood in managing autism spectrum disorder symptoms in children aged 4–8 years.
, , , et al
PCC
miRNAs and Impact on Schizophrenia Management
Narrative Review

miRNAs and Impact on Schizophrenia Management

April 7, 2022

This review summarizes the most important findings of experimental investigations aimed at identifying the role of human miRNAs in schizophrenia management, as well as the expression of different miRNAs...
, , , et al
PCC
Commentary

Psychiatric Disorders and COVID-19 Outcomes

January 20, 2022

Patients with psychiatric disorders may be at greater risk of experiencing adverse outcomes from COVID-19. Read on to find out more.
, ,
PCC
Brief Report

Benzodiazepine Interaction With COVID-19 Drugs

October 28, 2021

In this report, the authors review the potential drug-to-drug interactions and safety of using benzodiazepines with COVID-19 antiviral drugs.
, , , et al
PCC
Case Report

Bulimia-Induced Purging Followed by Cannabis-Induced Hyperemesis

March 25, 2021

Here, the authors present a unique presentation of an adolescent girl with a history of bulimia nervosa with multiple chronic episodes of voluntary purging, which were immediately followed by...
, , , et al
PCC
Letter to the Editor

Interactions With IL-6 Inhibitors and Agents for Opioid Use: Drs Mansuri and Colleagues Reply

February 18, 2021

In this letter to the editor, the authors reply to Kow and Hasan.
, , , et al
PCC
Commentary

Opioid Use Disorder Treatment and Interaction With COVID-19 Medication

July 2, 2020

In this commentary, the authors discuss the potential interactions of opioid use disorder treatments with novel COVID-19 medications.
, , , et al
PCC
Commentary

Interactions of Ritonavir/Lopinavir With Psychiatric Medications: A COVID-19 Perspective

June 18, 2020

In this commentary, the authors discuss the potential interactions of ritonavir/lopinavir with psychiatric medications in the context of COVID-19.
, , , et al
PCC
Commentary

Potential Interactions of Remdesivir With Psychotropics

May 28, 2020

The FDA has approved remdesivir for severe COVID-19 in children and adults. This commentary reviews potential interactions of remdesivir with psychotropic medications.
, , , et al
PCC
Letter to the Editor

Pimavanserin: A 2019 Clarification on the FDA Update

December 26, 2019

The authors of this letter to the editor comment on a previously published report on pimavanserin in The Primary Care Companion for CNS Disorders.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe